The spike of acute angle closure after the epidemic downgrade of COVID-19 management: a hospital-based comparative study from China
International Ophthalmology · 2024
DOI: 10.1007/s10792-024-03228-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Ophthalmology, 2024. Verfasst von Qi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Lab of Ophthalmology, Zhejiang Provincia…. Hauptthemen laut MEDLINE: COVID-19, Glaucoma, Angle-Closure, SARS-CoV-2. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Provincial Nature Science Foundation of Zhejiang Province of China.
Abstract (Originalsprache)
PURPOSE: To analyse and compare the clinical characteristics and treatment outcomes of patients with acute angle closure (AAC) who presented before the COVID-19 pandemic, during the COVID-19 management and after their downgrading. METHODS: Consecutive AAC patients were recruited from our hospital and divided into three groups: those treated before the COVID-19 pandemic (Group1), during the COVID-19 management (Group2) and after the management downgrade (Group3). The demographic variables, clinical characteristics, treatment methods and therapeutic outcomes of the groups were compared. RESULTS: When compared to Groups1 and 2, Group3 showed a significantly higher incidence of AAC (0.27%, P < 0.001), a longer time from symptoms to treatment (TST; 160.88 ± 137.05 h, P = 0.031) and worse uncorrected visual acuity (P = 0.009) at presentation. In Group3, 68.9% had a history of COVID-19 and 28.5% developed ocular symptoms of AAC after taking medication for COVID-19 symptoms. The average time from the onset of COVID-19 to the appearance of eye symptoms was 3.21 ± 4.00 days. CONCLUSIONS: The COVID-19 has had a multifaceted impact on the incidence of AAC. Therefore, it is crucial to strengthen health education on glaucoma, especially AAC. The prevention and timely treatment of AAC should be emphasised to combat global blindness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Lab of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engin…
- Department of Ophthalmology, Fenghua People's Hospital, Ningbo, China.
Förderung
- National Nature Science Foundation of China
- Provincial Nature Science Foundation of Zhejiang Province of China
Zitieren
APA
Zhang, Q., Ye, Z., Cheng, B., Wang, K., & Chen, M. (2024). The spike of acute angle closure after the epidemic downgrade of COVID-19 management: a hospital-based comparative study from China. International Ophthalmology. https://doi.org/10.1007/s10792-024-03228-0
Vancouver
Zhang Q, Ye Z, Cheng B, Wang K, Chen M. The spike of acute angle closure after the epidemic downgrade of COVID-19 management: a hospital-based comparative study from China. International Ophthalmology. 2024. doi:10.1007/s10792-024-03228-0
BibTeX
@article{Zhang2024,
author = {Zhang, Qi and Ye, Zifan and Cheng, Bo and Wang, Kaijun and Chen, Min},
title = {The spike of acute angle closure after the epidemic downgrade of COVID-19 management: a hospital-based comparative study from China},
journal = {International Ophthalmology},
year = {2024},
doi = {10.1007/s10792-024-03228-0}
}
EUVIMED